Page last updated: 2024-08-24

5-methylcytosine and Epithelial Ovarian Cancer

5-methylcytosine has been researched along with Epithelial Ovarian Cancer in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Arora, A; Bisht, D; Sachan, M1
Li, PL; Wang, TZ; Zhang, LY; Zhang, XC1

Reviews

1 review(s) available for 5-methylcytosine and Epithelial Ovarian Cancer

ArticleYear
Role of DNA De-methylation intermediate '5-hydroxymethylcytosine' in ovarian cancer management: A comprehensive review.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 155

    Topics: 5-Methylcytosine; Carcinoma, Ovarian Epithelial; DNA; DNA Methylation; Epigenesis, Genetic; Female; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms

2022

Other Studies

1 other study(ies) available for 5-methylcytosine and Epithelial Ovarian Cancer

ArticleYear
Prognostic values of 5-hmC, 5-mC and TET2 in epithelial ovarian cancer.
    Archives of gynecology and obstetrics, 2015, Volume: 292, Issue:4

    Topics: 5-Methylcytosine; Adult; Aged; Biomarkers, Tumor; Carcinoma, Ovarian Epithelial; Case-Control Studies; Cytosine; Dioxygenases; DNA Methylation; DNA-Binding Proteins; Female; Humans; Immunohistochemistry; Lymphatic Metastasis; Middle Aged; Neoplasm Grading; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Prognosis; Proto-Oncogene Proteins; Survival Analysis

2015